AIHealthcare Analytics

Overview

Israel launched its first regulatory sandbox for artificial intelligence in healthcare, becoming one of the earliest countries to create a structured experimental regulatory environment specifically for healthcare AI. The program is a joint initiative of the Israel Innovation Authority and the Ministry of Health.

Program Structure

The sandbox allows selected companies to develop and test AI healthcare applications under regulatory supervision, with reduced compliance burden during the development phase in exchange for data sharing and safety reporting. The model is designed to accelerate innovation while maintaining government oversight — a balance that has been difficult to achieve under traditional medical device regulatory frameworks.

Pulsenmore's Participation

Pulsenmore, an AI-enabled remote ultrasound company, was selected for the program and awarded a $1 million AI development project (PR Newswire). Pulsenmore shares reportedly soared after the announcement (Yahoo Finance), reflecting investor enthusiasm for companies gaining early access to regulatory sandbox status. Pulsenmore's inclusion in the program provides a case study for how the sandbox model functions in practice.

Global Significance

Israel's sandbox joins a small number of similar programs globally (including the UK's MHRA sandbox and Singapore's regulatory innovation initiatives) as models for how governments can accelerate healthcare AI deployment while managing safety risks. The program's outcomes will be watched by regulators in the US, EU, and other jurisdictions considering similar approaches.